Title : Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy.

Pub. Date : 2013 Jul

PMID : 23633496

1 Functional Relationships(s)
Compound Name
Protein Name
1 Rare APOA5 promoter region variants were associated with decreased HDL-C and apoA-I levels in response to fenofibric acid therapy; rare missense variants were associated with increased TG response to combination therapy. fenofibric acid apolipoprotein A1 Homo sapiens